Abuse of monoamine oxidase inhibitors.
Monoamine oxidase inhibitors, like other antidepressants, generally are considered free of risk for abuse. There is, however, some evidence that MAOIs possess dependence and abuse potential for some patients. We will review the available literature and describe three current cases. Recommendations for treatment are discussed briefly.
Baumbacher
G
G
Langley Porter Psychiatric Institute, University of California, San Francisco 94143.
Hansen
M S
MS
D000328:Adult; D001714:Bipolar Disorder / Q000139:chemically induced; D003866:Depressive Disorder / Q000188:drug therapy* / Q000534:rehabilitation; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors; D010624:Phenelzine / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D012649:Self Concept; D019966:Substance-Related Disorders / Q000175:diagnosis
D008996:Monoamine Oxidase Inhibitors; D010624:Phenelzine